Monograph Eligibility To Include U.S. Rx-Only Drugs With Foreign OTC Data
This article was originally published in The Tan Sheet
Executive Summary
A drug marketed OTC in foreign countries but limited to Rx use in the U.S. could be considered for eligibility in the OTC monograph system under FDA's final rule on "material time, material extent" criteria, published in the Federal Register Jan. 23
You may also be interested in...
FDA Seeks Data On Triclosan, Considers OTC Acne Monograph Inclusion
FDA is issuing a call-for-data for information on the safety and effectiveness of triclosan when used as an anti-acne ingredient
FDA Seeks Data On Triclosan, Considers OTC Acne Monograph Inclusion
FDA is issuing a call-for-data for information on the safety and effectiveness of triclosan when used as an anti-acne ingredient
FDA Seeks Data On Triclosan, Considers OTC Acne Monograph Inclusion
FDA is issuing a call-for-data for information on the safety and effectiveness of triclosan when used as an anti-acne ingredient